SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-000733
Filing Date
2020-02-12
Accepted
2020-02-12 17:24:31
Documents
107
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kala-20191231x10k.htm 10-K 2834329
2 EX-4.3 kala-20191231ex439fe4e65.htm EX-4.3 19124
3 EX-21.1 kala-20191231ex21156cbf0.htm EX-21.1 4694
4 EX-23.1 kala-20191231ex23114692e.htm EX-23.1 3259
5 EX-31.1 kala-20191231ex311177fb3.htm EX-31.1 11201
6 EX-31.2 kala-20191231ex312f959a3.htm EX-31.2 11187
7 EX-32.1 kala-20191231ex3215debf5.htm EX-32.1 6703
8 EX-32.2 kala-20191231ex322c2f60a.htm EX-32.2 6834
9 GRAPHIC kala20191231x10k001.jpg GRAPHIC 35030
10 GRAPHIC kala20191231x10k002.jpg GRAPHIC 57530
11 GRAPHIC kala20191231x10k003.jpg GRAPHIC 49193
12 GRAPHIC kala20191231x10k004.jpg GRAPHIC 110652
13 GRAPHIC kala20191231x10k005.jpg GRAPHIC 74544
14 GRAPHIC kala20191231x10k006.jpg GRAPHIC 148604
15 GRAPHIC kala20191231x10k007.jpg GRAPHIC 27111
16 GRAPHIC kala20191231x10k008.jpg GRAPHIC 29836
17 GRAPHIC kala20191231x10k009.jpg GRAPHIC 29695
18 GRAPHIC kala20191231x10k010.jpg GRAPHIC 125209
  Complete submission text file 0001558370-20-000733.txt   10141170

Data Files

Seq Description Document Type Size
19 EX-101.INS kala-20191231.xml EX-101.INS 1752181
20 EX-101.SCH kala-20191231.xsd EX-101.SCH 68435
21 EX-101.CAL kala-20191231_cal.xml EX-101.CAL 64862
22 EX-101.DEF kala-20191231_def.xml EX-101.DEF 212804
23 EX-101.LAB kala-20191231_lab.xml EX-101.LAB 575904
24 EX-101.PRE kala-20191231_pre.xml EX-101.PRE 441797
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38150 | Film No.: 20605628
SIC: 2834 Pharmaceutical Preparations